Author

David A. Gewirtz

Primary ORCID profile (0000-0003-0437-4934 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

David A. GewirtziD1 paper · Virginia Commonwealth University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Emmanuel K. Cudjoe· 1 shared Lynne W. Elmore· 1 shared S. Lauren Kyte· 1 shared Scott C. Henderson· 1 shared Tareq Saleh· 1 shared

Activity by Year

2017-2017 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Emmanuel K. Cudjoe

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Reversibility of chemotherapy-induced senescence is independent of autophagy and a potential model for tumor dormancy and cancer recurrence.

Tareq Saleh, Emmanuel K. Cudjoe, S. Lauren Kyte, Scott C. Henderson, Lynne W. Elmore, David A. Gewirtz

This study shows chemotherapy-induced senescence in tumor cells can be reversed without autophagy, suggesting senescence may be transient and linked to cancer recurrence.

bioRxiv · Jan 11, 2017 · PreprintCancer Biology